Three different B-cell depletion (anti-CD20 monoclonal antibodies) treatments for severe resistant systemic lupus erythematosus.
作者信息
Faria R M, Isenberg D A
出版信息
Lupus. 2010 Sep;19(10):1256-7. doi: 10.1177/0961203310373107. Epub 2010 Jun 9.
PMID:20534646
Abstract
摘要
相似文献
1
Three different B-cell depletion (anti-CD20 monoclonal antibodies) treatments for severe resistant systemic lupus erythematosus.三种不同的B细胞清除（抗CD20单克隆抗体）疗法用于治疗重度难治性系统性红斑狼疮。
Lupus. 2010 Sep;19(10):1256-7. doi: 10.1177/0961203310373107. Epub 2010 Jun 9.
2
[Molecular targets and their regulation in systemic lupus erythematosus and lupus nephritis].[系统性红斑狼疮和狼疮性肾炎中的分子靶点及其调控]
Nihon Jinzo Gakkai Shi. 2012;54(5):598-602.
3
4
[CD20 antibody for the treatment of systemic autoimmune diseases].用于治疗全身性自身免疫性疾病的CD20抗体
Nihon Rinsho. 2005 May;63 Suppl 5:728-33.
5
Anti-CD20 monoclonal antibody in rheumatoid arthritis and systemic lupus erythematosus.类风湿关节炎和系统性红斑狼疮中的抗CD20单克隆抗体
Handb Exp Pharmacol. 2008(181):163-81. doi: 10.1007/978-3-540-73259-4_8.
6
Rituximab - shadow, illusion or light?利妥昔单抗——阴影、幻象还是曙光？
Autoimmun Rev. 2012 Jun;11(8):563-7. doi: 10.1016/j.autrev.2011.10.013. Epub 2011 Oct 22.
7
Treatment of SLE with anti-CD20 monoclonal antibody.用抗CD20单克隆抗体治疗系统性红斑狼疮。
Curr Dir Autoimmun. 2005;8:193-205. doi: 10.1159/000082104.
8
Variability in the biological response to anti-CD20 B cell depletion in systemic lupus erythaematosus.系统性红斑狼疮中抗CD20 B细胞耗竭的生物学反应变异性。
Ann Rheum Dis. 2008 Dec;67(12):1724-31. doi: 10.1136/ard.2007.083162. Epub 2008 Feb 4.
9
Longterm clinical and immunological effects of anti-CD20 treatment in patients with refractory systemic lupus erythematosus.抗CD20治疗对难治性系统性红斑狼疮患者的长期临床和免疫学影响。
J Rheumatol. 2008 May;35(5):826-33. Epub 2008 Apr 1.
10
Humanized anti-CD20 monoclonal antibody in the treatment of severe resistant systemic lupus erythematosus in a patient with antibodies against rituximab.人源化抗CD20单克隆抗体治疗一名对利妥昔单抗产生抗体的重症难治性系统性红斑狼疮患者
Rheumatology (Oxford). 2005 Apr;44(4):561-2. doi: 10.1093/rheumatology/keh533. Epub 2005 Jan 11.
引用本文的文献
1
Translational Mini-Review Series on B cell subsets in disease. Transitional B cells in systemic lupus erythematosus and Sjögren's syndrome: clinical implications and effects of B cell-targeted therapies.B 细胞亚群在疾病中的转化综述系列。系统性红斑狼疮和干燥综合征中的过渡性 B 细胞：临床意义和 B 细胞靶向治疗的影响。
Clin Exp Immunol. 2012 Jan;167(1):7-14. doi: 10.1111/j.1365-2249.2011.04460.x.
2
Targeting B cells for the treatment of SLE: the beginning of the end or the end of the beginning?靶向B细胞治疗系统性红斑狼疮：是终结的开始还是开始的结束？
Discov Med. 2010 Nov;10(54):416-24.
Zotero 插件